UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Holdings History for Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY)

Symbol: SGRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$17,003,436	1,100,546	+55,501	+5.3%	$15.45	Q4 2025
30 Sep 2025	0%	-0%	$22,614,775	1,045,045	-116,582	-10%	$21.64	Q3 2025
30 Jun 2025	0.01%	+0%	$25,822,968	1,161,627	+649,821	+127%	$22.23	Q2 2025
31 Mar 2025	0%	-0%	$12,155,393	511,806	-43,348		$23.75	Q1 2025
31 Dec 2024	0%	-0%	$11,752,611	555,154	-23,394	-4%	$21.17	Q4 2024
30 Sep 2024	0%	-0%	$18,652,387	578,548	-1,768	-0.3%	$32.24	Q3 2024
30 Jun 2024	0%	+0%	$13,805,716	580,316	+65,810	+13%	$23.79	Q2 2024
31 Mar 2024	0.01%	+0%	$15,347,713	514,506	+19,064	+3.8%	$29.83	Q1 2024
31 Dec 2023	0.01%	+0%	$15,849,190	495,442	+98,078	+25%	$31.99	Q4 2023
30 Sep 2023	0.01%	0%	$11,622,898	397,364	0		$29.25	Q3 2023
30 Jun 2023		0%	$13,369,018	387,845	0		$34.47 ^*	Q2 2023
31 Mar 2023	0.01%	+0%	$13,369,018	387,845	+3,494	+0.91%	$34.47	Q1 2023
31 Dec 2022	0.01%	+0%	$10,708,019	384,351	+62,456	+19%	$27.86	Q4 2022
30 Sep 2022	0%	-0%	$7,532,342	321,895	-51,536	-14%	$23.40	Q3 2022
30 Jun 2022	0.01%	-0%	$10,799,625	373,431	-9,946	-2.6%	$28.92	Q2 2022
31 Mar 2022	0.01%	-0%	$21,104,903	383,377	-17,423	-4.3%	$55.05	Q1 2022
31 Dec 2021	0.01%	-0%	$21,406,729	400,800	-12,462	-3%	$53.41	Q4 2021
30 Sep 2021	0.01%	+0.01%	$17,497,512	413,262	+378,797	+1099%	$42.34	Q3 2021
30 Jun 2021	0%	+0%	$2,296,058	34,465	+8,313	+32%	$66.62	Q2 2021
31 Mar 2021	0%	+0%	$1,157,487	26,152	+3,084	+13%	$44.26	Q1 2021
31 Dec 2020	0%	0%	$669,202	23,068	0		$29.01	Q4 2020
30 Sep 2020	0%	+0%	$505,190	23,068	+9,968	+76%	$21.90	Q3 2020
30 Jun 2020	0%	+0%	$151,567	13,100	+13,100	NEW	$11.57	Q2 2020
31 Dec 2016		-0%	$0	0	-15,200	-100%	$15.00	Q4 2016
30 Sep 2016	0%	0%	$308,000	15,200	0		$20.26	Q3 2016
30 Jun 2016	0%	+0%	$272,000	15,200	+15,200	NEW	$17.89	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.